Document is current
Any future updates will be listed below
-
Authors
Milovanovic, Petar
Braun, Julia
Hunn, Cynthia Alexandra
Lunkiewicz, Justyna
Tscholl, David Werner
Gasciauskaite, Greta
-
Funding
Funding for this research was provided by:
University of Zurich
- License Information
-
More Information
Article History
Received: 6 August 2024
Accepted: 30 October 2024
First Online: 15 November 2024
Declarations
:
: The Cantonal Ethics Committee of Zurich in Switzerland approved the study protocol. They issued a declaration of non-jurisdiction specifying that the research project did not fall into the scope of the Human Research Act (Business Management System for Ethics Committees Req-2023-00580). All participants signed written informed consent for the collected data in anonymized form. Study participation was voluntary and without financial compensation.
: We obtained written informed consent from all participants for the use of their data.
: DWT is first named an inventor of Visual Patient and Visual Patient Predictive technologies, for which the University of Zurich and Koninklijke Philips N.V. hold patents, patent applications, design protections, and trademarks. Joint-development and licensing agreements exist with Philips Medizin Systeme Böblingen GmbH, Böblingen, Germany; Koninklijke Philips N.V., Amsterdam, The Netherlands; Philips Research/Philips Electronics Nederland BV, Eindhoven, The Netherlands; and Philips USA, Cambridge, MA, USA. Within the framework of these agreements, DWT receives research funding, travel support, lecturing and consulting honoraria, and royalties in accordance with University of Zurich standard procedure. DWT participates in the Philips Patient Safety Advisory Board. DWT is an inventor of Visual Clot and Visual Blood technologies, with patent applications, design protections, and trademarks held by the University of Zurich. DWT is an inventor of Visual Hemofilter technology, for which the University of Zurich holds patent applications and design protections. In case of successful commercialization, DWT may receive royalties. DWT received travel support, lecturing, and consulting honoraria from Instrumentation Laboratory – Werfen, Bedford, MA, USA, the Swiss Foundation for Anaesthesia Research in Zurich, Switzerland, and the International Symposium on Intensive Care and Emergency Medicine in Brussels, Belgium.
